Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN Inc. CEO to Present at Piper Jaffray Health Care Conference

CHAPEL HILL, N.C., Jan. 31 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, announced that John R. Plachetka, Pharm. D., the company's chairman, president and chief executive officer, will make a presentation to investors and financial analysts during the U.S. Bancorp. Piper Jaffray Health Care Conference on Thursday, February 1, 2001, at 9:30 a.m. EST. A live webcast will be accessible through the following link:

http://www.gotoanalysts.com/healthcareconference

North Carolina-based POZEN Inc. is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. The company's initial focus is migraine, where it has built a robust portfolio of four product candidates through a combination of innovation and in-licensing. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."

POZEN is on the Internet at http://www.pozen.com .

CONTACT:
Matthew E. Czajkowski
Chief Financial Officer of Pozen
919-490-0012
or
General Inquiries
Marilyn Windsor of The Financial Relations Board
312-640-6692


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.